Difference between revisions of "Serimmune antibody analysis results"
(Created page with "The [https://serimmune.com/covid19study/ Serimmune COVID-19 Study] is a longitudinal research study conducted by the Serimmune company. The study uses the company's "Serum Epi...") |
(Sprague serimmune data) |
||
| Line 16: | Line 16: | ||
|- | |- | ||
| [[User:Madprime]] || 2022-02-03 || [[File:TOEAIX_20220203.pdf]] || Moderna vaccine (two shots, plus booster) | | [[User:Madprime]] || 2022-02-03 || [[File:TOEAIX_20220203.pdf]] || Moderna vaccine (two shots, plus booster) | ||
| + | |- | ||
| + | |[[User:Sprague]] | ||
| + | |2022-12-14 | ||
| + | | | ||
| + | |Pfizer vaccine (two shots, pre-booster) | ||
|} | |} | ||
| Line 22: | Line 27: | ||
None yet; [[User:Madprime]] anticipates having one as they were infected with COVID-19 (positive home antigen test on 2022-05-01). | None yet; [[User:Madprime]] anticipates having one as they were infected with COVID-19 (positive home antigen test on 2022-05-01). | ||
| − | =Other results= | + | = Other results= |
In addition to COVID-19 related antibody analyses, the study shares research analysis of antibodies related to infectious diseases (Lyme Disease, Ehrlichiosis, Anaplasmosis, Babesiosis, Chagas Disease) and autoimmune conditions (Celiac Disease). | In addition to COVID-19 related antibody analyses, the study shares research analysis of antibodies related to infectious diseases (Lyme Disease, Ehrlichiosis, Anaplasmosis, Babesiosis, Chagas Disease) and autoimmune conditions (Celiac Disease). | ||
| Line 28: | Line 33: | ||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
| − | ! Individual !! Date !! Report !! Notes | + | !Individual!!Date!!Report!!Notes |
|- | |- | ||
| − | | [[User:Madprime]] || 2022-02-03 || [[File:TOEAIX_Expanded_20220203.pdf]] || No medical history related to these analyses. | + | | [[User:Madprime]]||2022-02-03||[[File:TOEAIX_Expanded_20220203.pdf]]||No medical history related to these analyses. |
|} | |} | ||
Revision as of 04:44, 27 May 2022
The Serimmune COVID-19 Study is a longitudinal research study conducted by the Serimmune company. The study uses the company's "Serum Epitope Repertoire Analysis (SERA) technology" to study antibody responses, especially in the context of COVID-19 vaccination and exposure.
The study returns research-grade results (not intended for diagnostic clinical use) to participants. As described in the study consent document, these results are not clinically validated and not meant to serve as a clinical assay. They are, nevertheless, interesting to look at!
The study is planned to last five years, with blood samples collected every six months. Samples are self-collected by participants using a home collection kit and sent by mail.
Project Infobox 
| |
|---|---|
| Self researcher(s) | User:Madprime |
| Related tools | |
| Related topics | |
Builds on project(s) |
|
| Has inspired | Projects (0) |
SARS-CoV-2 Antibody Analyses
Vaccine-only responses
| Individual | Date | Report | Notes |
|---|---|---|---|
| User:Madprime | 2022-02-03 | File:TOEAIX 20220203.pdf | Moderna vaccine (two shots, plus booster) |
| User:Sprague | 2022-12-14 | Pfizer vaccine (two shots, pre-booster) |
Post-exposure responses
None yet; User:Madprime anticipates having one as they were infected with COVID-19 (positive home antigen test on 2022-05-01).
Other results
In addition to COVID-19 related antibody analyses, the study shares research analysis of antibodies related to infectious diseases (Lyme Disease, Ehrlichiosis, Anaplasmosis, Babesiosis, Chagas Disease) and autoimmune conditions (Celiac Disease).
| Individual | Date | Report | Notes |
|---|---|---|---|
| User:Madprime | 2022-02-03 | File:TOEAIX Expanded 20220203.pdf | No medical history related to these analyses. |
Linked content on this wiki
(The content in the table below is automatically created. See Template:Project Queries for details. If newly linked pages do not appear here, click on "More" and "Refresh".)
| Project that build on this project |
|---|
| We talked about this project in the following meetings |
|---|
| 2022-05-26 Self-Research Chat, 2022-06-02 Self-Research Chat, 2022-07-14 Self-Research Chat, 2022-09-15 Self-Research Chat, 2022-12-29 Self-Research Chat |